These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11349874)

  • 1. Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas.
    Ni HT; Spellman SR; Jean WC; Hall WA; Low WC
    J Neurooncol; 2001 Jan; 51(1):1-9. PubMed ID: 11349874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells.
    Xu M; Yao Y; Hua W; Wu Z; Zhong P; Mao Y; Zhou L; Luo F; Chu Y
    J Neurooncol; 2014 Feb; 116(3):497-504. PubMed ID: 24398615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model.
    Grauer OM; Sutmuller RP; van Maren W; Jacobs JF; Bennink E; Toonen LW; Nierkens S; Adema GJ
    Int J Cancer; 2008 Apr; 122(8):1794-802. PubMed ID: 18076066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.
    Liau LM; Black KL; Prins RM; Sykes SN; DiPatre PL; Cloughesy TF; Becker DP; Bronstein JM
    J Neurosurg; 1999 Jun; 90(6):1115-24. PubMed ID: 10350260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.
    Prins RM; Odesa SK; Liau LM
    Cancer Res; 2003 Dec; 63(23):8487-91. PubMed ID: 14679014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats.
    Zhu X; Lu C; Xiao B; Qiao J; Sun Y
    J Neurooncol; 2005 Aug; 74(1):9-17. PubMed ID: 16078102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.
    Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H
    J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.
    Renner DN; Jin F; Litterman AJ; Balgeman AJ; Hanson LM; Gamez JD; Chae M; Carlson BL; Sarkaria JN; Parney IF; Ohlfest JR; Pirko I; Pavelko KD; Johnson AJ
    PLoS One; 2015; 10(5):e0125565. PubMed ID: 25933216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
    Newcomb EW; Demaria S; Lukyanov Y; Shao Y; Schnee T; Kawashima N; Lan L; Dewyngaert JK; Zagzag D; McBride WH; Formenti SC
    Clin Cancer Res; 2006 Aug; 12(15):4730-7. PubMed ID: 16899624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells pulsed with tumor extract-cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor.
    Aoki H; Mizuno M; Natsume A; Tsugawa T; Tsujimura K; Takahashi T; Yoshida J
    Cancer Immunol Immunother; 2001 Nov; 50(9):463-8. PubMed ID: 11761440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice.
    Pellegatta S; Poliani PL; Corno D; Grisoli M; Cusimano M; Ubiali F; Baggi F; Bruzzone MG; Finocchiaro G
    Neurol Res; 2006 Jul; 28(5):527-31. PubMed ID: 16808884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-beta gene therapy for malignant glioma in an experimental mouse intracranial glioma.
    Saito R; Mizuno M; Nakahara N; Tsuno T; Kumabe T; Yoshimoto T; Yoshida J
    Int J Cancer; 2004 Sep; 111(5):777-82. PubMed ID: 15252850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors.
    Agarwalla P; Barnard Z; Fecci P; Dranoff G; Curry WT
    J Immunother; 2012 Jun; 35(5):385-9. PubMed ID: 22576343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
    Tsugawa T; Kuwashima N; Sato H; Fellows-Mayle WK; Dusak JE; Okada K; Papworth GD; Watkins SC; Gambotto A; Yoshida J; Pollack IF; Okada H
    Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas.
    Pellegatta S; Poliani PL; Corno D; Menghi F; Ghielmetti F; Suarez-Merino B; Caldera V; Nava S; Ravanini M; Facchetti F; Bruzzone MG; Finocchiaro G
    Cancer Res; 2006 Nov; 66(21):10247-52. PubMed ID: 17079441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.
    Herrlinger U; Kramm CM; Johnston KM; Louis DN; Finkelstein D; Reznikoff G; Dranoff G; Breakefield XO; Yu JS
    Cancer Gene Ther; 1997; 4(6):345-52. PubMed ID: 9408604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas.
    Ciesielski MJ; Apfel L; Barone TA; Castro CA; Weiss TC; Fenstermaker RA
    Cancer Immunol Immunother; 2006 Dec; 55(12):1491-503. PubMed ID: 16485128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma.
    Pellegatta S; Valletta L; Corbetta C; Patanè M; Zucca I; Riccardi Sirtori F; Bruzzone MG; Fogliatto G; Isacchi A; Pollo B; Finocchiaro G
    Acta Neuropathol Commun; 2015 Jan; 3():4. PubMed ID: 25849072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma.
    Ciesielski MJ; Kozbor D; Castanaro CA; Barone TA; Fenstermaker RA
    Cancer Immunol Immunother; 2008 Dec; 57(12):1827-35. PubMed ID: 18438666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.
    Yamanaka R; Zullo SA; Tanaka R; Blaese M; Xanthopoulos KG
    J Neurosurg; 2001 Mar; 94(3):474-81. PubMed ID: 11235953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.